It's critically important that the companies that support cell and gene therapies comply with national and international regulations. Cryoport created Chain of Compliance to ensure the safety and security of these new, fragile treatments. In this short video, In our new video, Cryoport Vice President of Quality Assurance and Regulatory Affairs, along with Chief Commercial Officer Mark Sawicki, explain how we created and implemented Chain of Compliance ™.
It's critically important that the companies that support cell and gene therapies comply with national and international regulations. Cryoport created Chain of Compliance to ensure the safety and security of these new, fragile treatments. In this short video, In our new video, Cryoport Vice President of Quality Assurance and Regulatory Affairs, along with Chief Commercial Officer Mark Sawicki, explain how we created and implemented Chain of Compliance ™.
0 Comments